Cerus CorpCERS

NasdaqHealthcareSurgical & Medical Instruments & Apparatus
Price (close)
$2.62
Market cap
$525.5M
P/E
—
Revenue (TTM)
$233.8M
Net income
-$6.8M
Dividend yield
—
1-year total return
73.5%
Net margin
—
Revenue growth
—
Debt / equity
—

What Cerus Corp does.

No business description on file yet.

Revenue and profit, by fiscal year.

Fiscal year202020212022202320242025
Revenue$114.2M$159.5M$188.3M$186.8M$201.3M$233.8M
Net income-$59.9M-$54.4M-$42.8M-$37.5M-$20.9M-$15.6M
Free cash flow-$43.4M-$34.8M-$27.6M-$47.8M$8.5M$1.1M

More on CERS.

Figures from Cerus Corp's filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.